The Rise of Local Innovation: How Asia Pacific's Own Pharma Sector is Driving Growth
While the Asia Pacific CRO market has been largely driven by outsourcing from global pharmaceutical companies, a new force is emerging: the region's own pharmaceutical and biotechnology sector. Countries like China, India, and South Korea have a growing number of innovative local companies that are developing their own drugs and treatments. These companies are increasingly turning to local CROs to help them navigate the clinical trial process. This rise of local innovation is creating a strong domestic demand for CRO services and is a key factor driving the growth of the Asia Pacific CRO market. This trend is a sign that the region is not just a destination for outsourcing, but also a source of innovation in its own right. This domestic growth is a major driver of the Asia Pacific cro market.